MacroGenics Inc — Cash Flow (NASDAQ:MGNX) | MetaTrader

Open full chart

Financials

Overview Statement Statistics Dividends

Quarterly Annual

Cash from operating activities 111.9 M143.83 M86.96 M78.2 M68.37 M 162.47 M Cash from investing activities 7.79 M36.61 M70.72 M80.08 M149.3 M 89.57 M Cash from financing activities 174.34 M122.78 M1.66 M150.36 M960 K 69.61 M Free cash flow 105.99 M137.63 M83.34 M76.44 M64.67 M 160.18 M

News

BioLife Solutions, Inc. (BLFS) Surpasses Q4 Earnings and Revenue Estimates

MacroGenics hisseleri FDA’nın kısmi klinik durdurma kararıyla düştü

MacroGenics stock falls after FDA places partial clinical hold

Why Is MacroGenics Stock Sinking Tuesday? - Macrogenics (NASDAQ:MGNX)

Sanofi's Teizeild Gets EU Approval for Treating Type 1 Diabetes

FDA Accepts SNY Filing for Expanded Use of T1D Drug in Young Children

Thanksgiving: Top 10 Most Innovative BioPharma Drugs In Phase 3

MacroGenics (MGNX) Q3 Earnings and Revenues Surpass Estimates

MacroGenics Inc kazancı $0,68 ile beklentilere göre daha iyi, kâr ise beklentilere göre yüksek

MacroGenics Inc earnings beat by $0.68, revenue topped estimates

MacroGenics (MGNX) Forms 'Hammer Chart Pattern': Time for Bottom Fishing?

Stryker (SYK) Q3 Earnings and Revenues Beat Estimates